SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/51031"
 

Search: onr:"swepub:oai:gup.ub.gu.se/51031" > Epigenetic loss of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.

Ropero, Santiago (author)
Setien, Fernando (author)
Espada, Jesus (author)
show more...
Fraga, Mario F (author)
Herranz, Michel (author)
Asp, Julia, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för laboratoriemedicin, Avdelningen för klinisk kemi/transfusionsmedicin,Institute of Laboratory Medicine, Dept of Clinical Chemistry/Transfusion Medicine
Benassi, Maria Serena (author)
Franchi, Alessandro (author)
Patiño, Ana (author)
Ward, Laura S (author)
Bovee, Judith (author)
Cigudosa, Juan C (author)
Wim, Wuyts (author)
Esteller, Manel (author)
show less...
 (creator_code:org_t)
2004-09-22
2004
English.
In: Human molecular genetics. - : Oxford University Press (OUP). - 0964-6906 .- 1460-2083. ; 13:22, s. 2753-65
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Germline mutations in the Exostoses-1 gene (EXT1) are found in hereditary multiple exostoses syndrome, which is characterized by the formation of osteochondromas and an increased risk of chondrosarcomas and osteosarcomas. However, despite its putative tumor-suppressor function, little is known of the contribution of EXT1 to human sporadic malignancies. Here, we report that EXT1 function is abrogated in human cancer cells by transcriptional silencing associated with CpG island promoter hypermethylation. We also show that, at the biochemical and cellular levels, the epigenetic inactivation of EXT1, a glycosyltransferase, leads to the loss of heparan sulfate (HS) synthesis. Reduced HS production can be reversed by the use of a DNA demethylating agent. Furthermore, the re-introduction of EXT1 into cancer cell lines displaying methylation-dependent silencing of EXT1 induces tumor-suppressor-like features, e.g. reduced colony formation density and tumor growth in nude mouse xenograft models. Screening a large collection of human cancer cell lines (n=79) and primary tumors (n=454) from different cell types, we found that EXT1 CpG island hypermethylation was common in leukemia, especially acute promyelocytic leukemia and acute lymphoblastic leukemia, and non-melanoma skin cancer. These findings highlight the importance of EXT1 epigenetic inactivation, leading to an abrogation of HS biosynthesis, in the processes of tumor onset and progression.

Keyword

Animals
Antineoplastic Agents
therapeutic use
Cell Line
Tumor
CpG Islands
DNA Methylation
Epigenesis
Genetic
Female
Gene Expression Regulation
Neoplastic
genetics
Gene Silencing
Genes
Tumor Suppressor
Heparitin Sulfate
biosynthesis
deficiency
Humans
Leukemia
Lymphocytic
Acute
drug therapy
genetics
metabolism
Leukemia
Promyelocytic
Acute
drug therapy
genetics
metabolism
Mice
Mice
Nude
Mutation
Missense
N-Acetylglucosaminyltransferases
biosynthesis
genetics
Neoplasms
Experimental
metabolism
pathology
Promoter Regions (Genetics)
Skin Neoplasms
genetics
metabolism
Transplantation
Heterologous
Tretinoin
therapeutic use

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view